Oncternal Therapeutics Inc (ONCT) stock is up 72.93% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives ONCT stock a score of 72 out of a possible 100.
That rank is primarily influenced by a fundamental score of 92. In addition to the average rating from Wall Street analysts, ONCT stock has a mean target price of 14.5. This means analysts expect the stock to rise 138.88% over the next 12 months. ONCT's rank also includes a long-term technical score of 79. The short-term technical score for ONCT is 46.
What's Happening with ONCT Stock Today
Oncternal Therapeutics Inc (ONCT) stock has fallen -5.01% while the S&P 500 is lower by -0.15% as of 11:51 AM on Wednesday, Mar 3. ONCT is lower by -$0.32 from the previous closing price of $6.39 on volume of 1,007,893 shares. Over the past year the S&P 500 has risen 28.67% while ONCT is up 72.93%. ONCT lost -$1.14 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Oncternal Therapeutics Inc (ONCT) Stock.
